Empirico
Bill McLeod is currently the Chief Financial Officer at Empirico Inc., a biotechnology company. With a background in finance and extensive experience in various roles, including Managing Director at Eaton Partners and Senior Managing Director at Stifel Financial Corp., Bill has a strong foundation in equity capital markets. Bill holds a Master of Business Administration from The University of Chicago Booth School of Business and a Bachelor of Business Administration from Southern Methodist University.
This person is not in any teams
Empirico
1 followers
Empirico is a biotechnology company focused on the discovery and development of novel medicines which are designed to mimic naturally-occurring genetic variants that confer beneficial effects on health and disease. Empirico’s two foundational and proprietary technology platforms - the Precision Insights Platform™ for genetically-validated target discovery and siRCH™ for the discovery and development of siRNA medicines - are used separately and in tandem to enable Empirico and our collaborators from the discovery and validation of novel targets to the development of clinically-viable therapeutics. Empirico’s exceptional internal capabilities, augmented by those of its partners, are driving the advancement of a growing and differentiated pipeline of wholly-owned and partnered programs. Empirico is headquartered in San Diego, CA with a major second site in Madison, WI.